Clinical trial
Psychosocial Therapy and Risperidone Treatment in Work Performance in…
NCT00333177 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00333177 |
|---|---|
| Title | Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia |
| Official title | Developmental Processes in Schizophrenic Disorders: Cognitive Remediation, Medication Adherence, and Work Outcome in Recent-Onset Schizophrenia |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Behavioral, Drug |
| Interventions | Cognitive remediation training (CT), Healthy behavior training (HBT), Risperidone, administered orally (Oral Ris), administered via injection (RLAI) |
| Enrollment | 92 |
| Start date | Mar 1, 2006 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Jun 2, 2006 |
| Last update posted | Mar 26, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: